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Abstract
Endoscopic transpapillary gallbladder drainage for symptomatic gallbladder disease is a safe and effective bridge therapy in
patients at high risk for surgery or who have terminal liver disease awaiting transplantation. However, there are few reports
on long-term results in terms of stent patency and clinical course. We investigated the long-term patency and clinical course
after endoscopic transpapillary gallbladder stenting (ETGS) in patients who were unsuitable for cholecystectomy with
symptomatic gallbladder disease. ETGS using a 7 F double-pigtail stent between the gallbladder and the duodenum was
performed successfully in 79.3% in our institutions. Postprocedure complications were mild pancreatitis (8.7%) and
cholestasis (8.7%), all of which resolved with conservative management. During the follow-up period (median 586 days,
range 11–1403 days), median stent patency was 760 days, as determined by the Kaplan-Meier method. As a primary therapy,
ETGS is technically feasible and provide long-term stent patency without the need for scheduled stent exchanges in patients
who are unsuitable for cholecystectomy. This article is part of an expert video encyclopedia.
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Video Related to this Article
Techniques
• Patients’ inclusion criteria:
J Symptomatic gallbladder diseases with advanced liver
cirrhosis (Child-Pugh class C) or poor surgical risk due
to severe comorbid conditions.
J Patients who had refused percutaneous cholecysto-
stomy.
• Endoscopic procedure: endoscopic transpapillary gall-
bladder stenting (ETGS) technique.
Materials
• Duodenoscope: TJF 240; Olympus Optical Co., Ltd.,
Tokyo, Japan.
J Guide wires
J 0.035-inch-diameter, 450-cm-long hydrophilic jagwire
catheter tip; Boston Scientiﬁc Corp., Natick, MA, USA;
J 0.035-inch-hydrophilic Radifocus guidewire (stiff type);
Terumo, Tokyo, Japan; or
J 0.035-inch-diameter, 480-cm-long, hydrophilic, slip-
coat tip Tracer guidewire; Wilson-Cook Medical Inc.,
Winston-Salem, NC, USA.
• Cannulating catheters: the standard catheter, pull-sphinc-
terotome, or rotating sphincterotome; Autotome Rx; Bos-
ton Scientiﬁc, Natick, MA, USA.
• Plastic stent: 7(insert thin space)Fr, 7–15-cm-long double
pigtail polyethylene plastic stent; Zimmon and/or Wilson-
Cook Medical, Winston-Salem, NC, USA.
Background and Endoscopic Procedures
Background
Endoscopic transpapillary gallbladder drainage for symptom-
atic gallbladder disease is a safe and effective bridge therapy in
patients at high risk for surgery or who have terminal liver
disease awaiting transplantation. However, the long-term pa-
tency and clinical course after endoscopic transpapillary gall-
bladder stenting (ETGS) in patients with symptomatic
gallbladder disease is limited.
Endoscopic Procedures
Following an overnight fast, all patients underwent ERCP with
a standard duodenoscope (TJF 240; Olympus Optical Co.,
Ltd., Tokyo, Japan) in the prone or lateral position,
after sedation with intravenous midazolam (0.05 mg kg1)
and/or propofol (0.5 mg kg1). Prophylactic antibiotics and
analgesics were permitted. Access to the cystic duct and gall-
bladder was attempted with one of the guidewires, i.e., 0.035-
in. diameter, 450-cm long hydrophilic Jagwire catheter tip
(Boston Scientiﬁc Corp., Natick, MA, USA); 0.035-in. hydro-
philic Radifocus guidewire (Stiff type; Terumo, Tokyo, Japan);
or 0.035-in. diameter, 480-cm long, hydrophilic, slip-coat tip
Tracer guidewire (Wilson-Cook Medical Inc., Winston-Salem,
NC, USA), through cannulating catheters, including the
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standard catheter, pull sphincterotome, or rotating sphinc-
terotome (Autotome Rx; Boston Scientiﬁc Corp., Natick, MA,
USA). After successful bile duct cannulation, the guidewire-
preloaded catheter was advanced to negotiate the cystic duct.
The distance between the gallbladder and duodenum was
measured by pulling the catheter conveniently outside the
endoscope until it traversed from the gallbladder to the major
duodenal papilla. Based on the measured distance, a 7 Fr.,
7–15-cm long double-pigtail polyethylene plastic stent
(Zimmon; Wilson-Cook Medical Inc., Winston-Salem, NC,
USA) was placed between the gallbladder and duodenum.
Key Learning Points/Tips and Tricks
ETGS was technically feasible, safe, and effective in patients at
high risk for a cholecystectomy or who refused the operation
as a primary therapy.1–5 In the authors’ experience, ETGS may
provide long-term patency without scheduled stent exchanges
in at least 80% of patients over 2 years.6
Tips and Tricks
After successful bile duct cannulation, negotiation of the cystic
duct may be difﬁcult. In such cases, the guidewire-preloaded
catheter using rotating sphincterotome (Autotome Rx; Boston
Scientiﬁc Corp., Natick, MA, USA) may be helpful to negotiate
the cystic duct by rotation of papillotome to search the cystic
duct opening. Also, to search and see the conﬁguration of the
cystic duct, retrieval balloon occluded cholangiography is useful.
Nevertheless, sometimes cystic duct negotiation is difﬁcult in
cases of cystic duct-impacted stones or severe inﬂammatory
obstruction. In these cases, delayed endoscopic procedures after
conservative management may increase the success rate of
procedures. Repeated excessive manipulation of a guidewire
may cause cystic duct injury such as a perforation. Finally, to
perform successful procedures, experienced endoscopists and
skilled assistants are needed to control the guidewire and
papillotome.
Complications and Risk Factors
With respect to complications, there were no serious post-
procedure or delayed complications. In the authors’ experi-
ence, only two patients without endoscopic biliary
sphincterotomy (EST) developed mild post-ERCP pancreatitis.
In contrast, distal migration of the stent developed in two
patients who underwent EST for removal of common bile duct
(CBD) stones. A gallbladder in situ and biliary endoprosthesis
without EST may be risk factors for late complications such as
cholecystitis and cholangitis.
Scripted Voiceover
Time (min:sec) Voiceover text
00:00–00:07 This video shows the endoscopic transpapillary
gallbladder stenting in a patient with a gallstone
disease.
00:08–00:29 An 83-year-old woman admitted due to abdominal
pain and fever. Abdomen CT shows a distended
gallbladder (GB), wall thickening, and
pericholecystic ﬂuid collection. MRCP also shows
the same ﬁndings with multiple GB stones.
Because of a high-operative risk and the patient
refusing surgical operation, we planned to
perform endoscopic GB drainage.
00:30–00:38 ERC shows the selective CBD cannulation using a
Jag guidewire preloaded pull-type papillotome.
00:39–00:52 After successful guidewire placement into CBD,
contrast injection into CBD was done to search
for a cystic duct. At the same time, negotiate the
cystic duct by to- and fro- motion of a guidewire
as shown.
00:53–1:20 After successful bile duct cannulation, negotiation
of the cystic duct may be difﬁcult. In such
cases, the guidewire-preloaded catheter using
rotating sphincterotome, such as Autotome,
may be helpful in negotiating the cystic
duct by rotation of the papillotome to
search the cystic duct opening. Also, to
search and see the conﬁguration of the
cystic duct, retrieval balloon occluded
cholangiography is useful.
1:21–1:45 Nevertheless, sometimes cystic duct negotiation is
difﬁcult in cases of cystic duct impacted stones or
severe inﬂammatory obstruction. Repeated
excessive manipulation of a guidewire may cause
cystic duct injury. In this case, we attempted
frequent insertion and withdrawal of the
guidewire to introduce it into the gallbladder. To
perform successful procedures, experienced
endoscopists and skilled assistants are needed to
control the guidewire.
1:46–1:55 To coil the guidewire into the lumen of the
gallbladder, the papillotome needs to be pushed
into the cystic duct, and then insert a guidewire in
the lumen of the gallbladder as shown.
1:56–2:23 Following withdrawal of the papillotome, over the
guidewire, a 7 French double-pigtail plastic stent
was placed completely between the gallbladder
and duodenum as shown. With respect to
complications, there were no serious post-
procedure or delayed complications. However, a
gallbladder in situ and biliary endoprosthesis
without sphincterotomy may be a risk factor for
late complications such as cholecystitis and
cholangitis.
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